DPP4 Inhibition Increases Serum Catecholamines During Sustained ACE Inhibitor Treatment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Hypertension
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
DPP4 (Dipeptidyl Peptidase-4) Inhibition Increases Catecholamines Without Increasing Blood Pressure During Sustained ACE (Angiotensin-Converting Enzyme) Inhibitor Treatment
Hypertension 2022 Jan 20;[EPub Ahead of Print], JR Wilson, EM Garner, M Mashayekhi, SA Hubers, CE Ramirez Bustamante, SJ Kerman, H Nian, CA Shibao, NJ BrownFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.